Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17435996

Download in:

View as

General Info

PMID
17435996